Eribulin Mesylate in Treating Patients With Locally Advanced or Metastatic Cancer of the Urothelium and Kidney Dysfunction
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David I Quinn
City of Hope Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
26 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Tower Cancer Research Foundation
Beverly Hills, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- City of Hope Antelope Valley
Lancaster, California, United States
- Usc / Norris Comprehensive Cancer Center
Los Angeles, California, United States
- Contra Costa Regional Medical Center
Martinez, California, United States
- Veterans Administration Hospital - Martinez
Martinez, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- City of Hope South Pasadena
South Pasadena, California, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Decatur Memorial Hospital
Decatur, Illinois, United States
- Northshore University Healthsystem-Evanston Hospital
Evanston, Illinois, United States
- Ingalls Memorial Hospital
Harvey, Illinois, United States
- Duly Health and Care Joliet
Joliet, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Illinois Cancercare-Peoria
Peoria, Illinois, United States
- Central Illinois Hematology Oncology Center
Springfield, Illinois, United States
- Southern Illinois University School of Medicine
Springfield, Illinois, United States
- Fort Wayne Medical Oncology and Hematology Inc-Parkview
Fort Wayne, Indiana, United States
- Community Howard Regional Health
Kokomo, Indiana, United States
- Northern Indiana Cancer Research Consortium
South Bend, Indiana, United States
- University of Michigan Comprehensive Cancer Center
Ann Arbor, Michigan, United States
- Wayne State University/karmanos Cancer Institute
Detroit, Michigan, United States
- Oncology Care Associates Pllc
Saint Joseph, Michigan, United States
- Mercy Hospital Saint Louis
St Louis, Missouri, United States
- University of Pittsburgh Cancer Institute (upci)
Pittsburgh, Pennsylvania, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 23 Oct 2006
- Primary completion
- 9 Jul 2025
- Completion
- 9 Jul 2026
- Last update posted
- 11 Jul 2025
- Registered enrollment
- 132
- Registry id
- NCT00365157
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.